Condensed Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
	Mar. 31, 2018	Mar. 31, 2017
Revolving credit borrowings	$ 350,000	$ 1,000,000
Proceeds from Issuance or Sale of Equity	$ 3,056,981	0
Document Period End Date	Mar. 31, 2018
Cash flows from operating activities:
Net loss	$ (2,768,583)	(3,205,110)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	103,723	259,511
Amortization of Other Deferred Charges	116,546	0
Stock compensation expense	12,506	23,794
Change in assets and liabilities:
Accounts receivable, net	(1,986,794)	1,592,307
Inventories	975,732	(401,213)
Prepaid expenses and other current assets	143,590	14,886
Other assets	(4,677)	(7,593)
Accounts payable	(739,411)	707,076
Accrued compensation and employee benefits	44,015	70,627
Accrued expenses	(92,309)	(163,235)
Unearned revenue	62,365	(102,195)
Other liabilities	21,947	40,327
Net cash provided by (used in)	(4,111,350)	(1,170,818)
Cash flows from investing activities:
Increase (Decrease) in Trading Securities	(193)	(247)
Payments to Acquire Property, Plant, and Equipment	(35,344)	(94,371)
Net Cash Provided by (Used in) Investing Activities	(35,537)	(94,618)
Net Cash Provided by (Used in) Financing Activities [Abstract]
Net Cash Provided by (Used in) Financing Activities	3,406,981	1,000,000
Effect of Exchange Rate on Cash and Cash Equivalents	21,462	383,602
Cash and Cash Equivalents, Period Increase (Decrease)	(718,444)	118,166
Cash at beginning of year	2,253,952	1,954,422
Cash at end of period	$ 1,535,508	$ 2,072,588